Works matching IS 25233548 AND DT 2023 AND VI 43 AND IP 1

Results: 11

Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration?
Published in:
Cancer Communications, 2023, v. 43, n. 1, p. 75, doi. 10.1002/cac2.12393
By:
- Feng, Ruimei;
- Su, Qingling;
- Huang, Xiaoyin;
- Basnet, Til;
- Xu, Xin;
- Ye, Weimin
Publication type:
Article
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives.
Published in:
Cancer Communications, 2023, v. 43, n. 1, p. 3, doi. 10.1002/cac2.12392
By:
- Fang, Zengli;
- Meng, Qingcai;
- Xu, Jin;
- Wang, Wei;
- Zhang, Bo;
- Liu, Jiang;
- Liang, Chen;
- Hua, Jie;
- Zhao, Yingjun;
- Yu, Xianjun;
- Shi, Si
Publication type:
Article
Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21‐mediated ubiquitination/degradation of STAT1 in a GTP binding‐dependent modality.
Published in:
Cancer Communications, 2023, v. 43, n. 1, p. 123, doi. 10.1002/cac2.12386
By:
- Zhang, Lu;
- Li, Qingya;
- Yang, Jing;
- Xu, Penghui;
- Xuan, Zhe;
- Xu, Jianghao;
- Xu, Zekuan
Publication type:
Article
p21 is necessary for the beneficial effects of fasting during chemotherapy.
Published in:
Cancer Communications, 2023, v. 43, n. 1, p. 164, doi. 10.1002/cac2.12384
By:
- Plaza, Adrián;
- Pastor‐Fernández, Andrés;
- López‐Aceituno, José L.;
- Barradas, Marta;
- Pantoja, Cristina;
- Fernandez‐Marcos, Pablo J.
Publication type:
Article
Lysosomal TMEM9‐LAMTOR4‐controlled mTOR signaling integrity is required for mammary tumorigenesis.
Published in:
Cancer Communications, 2023, v. 43, n. 1, p. 159, doi. 10.1002/cac2.12382
By:
- Zhang, Shengzhe;
- Lee, Sung Ho;
- Nie, Litong;
- Huang, Yuanjian;
- Zou, Gengyi;
- Jung, Youn‐Sang;
- Jun, Sohee;
- Zhang, Jie;
- Lien, Esther M.;
- Chen, Junjie;
- Park, Jae‐Il
Publication type:
Article
circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer.
Published in:
Cancer Communications, 2023, v. 43, n. 1, p. 100, doi. 10.1002/cac2.12380
By:
- Yang, Yufei;
- Luo, Dakui;
- Shao, Yang;
- Shan, Zezhi;
- Liu, Qi;
- Weng, Junyong;
- He, Weijing;
- Zhang, Ruoxin;
- Li, Qingguo;
- Wang, Ziliang;
- Li, Xinxiang
Publication type:
Article
A phase Ib/II study of fruquintinib in combination with paclitaxel as the second‐line therapy for advanced gastric cancer.
Published in:
Cancer Communications, 2023, v. 43, n. 1, p. 150, doi. 10.1002/cac2.12379
By:
- Zhang, Yang;
- Wang, Zi‐Xian;
- Shen, Lin;
- Li, Jin;
- Huang, Jing;
- Su, Wei‐Guo;
- Zhang, Dong‐Sheng;
- Xu, Rui‐Hua
Publication type:
Article
Targeting RAS mutants in malignancies: successes, failures, and reasons for hope.
Published in:
Cancer Communications, 2023, v. 43, n. 1, p. 42, doi. 10.1002/cac2.12377
By:
- Yang, Hang;
- Zhou, Xinyi;
- Fu, Dongliang;
- Le, Chenqin;
- Wang, Jiafeng;
- Zhou, Quan;
- Liu, Xiangrui;
- Yuan, Ying;
- Ding, Kefeng;
- Xiao, Qian
Publication type:
Article
Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD‐3 study.
Published in:
Cancer Communications, 2023, v. 43, n. 1, p. 87, doi. 10.1002/cac2.12375
By:
- Nikšić, Maja;
- Minicozzi, Pamela;
- Weir, Hannah K;
- Zimmerman, Heather;
- Schymura, Maria J;
- Rees, Judith R;
- Coleman, Michel P;
- Allemani, Claudia
Publication type:
Article
Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocations.
Published in:
Cancer Communications, 2023, v. 43, n. 1, p. 154, doi. 10.1002/cac2.12370
By:
- Shmakova, Anna;
- Lomov, Nikolai;
- Viushkov, Vladimir;
- Tsfasman, Tatyana;
- Kozhevnikova, Yana;
- Sokolova, Darina;
- Pokrovsky, Vadim;
- Syrkina, Marina;
- Germini, Diego;
- Rubtsov, Mikhail;
- Vassetzky, Yegor
Publication type:
Article
Issue Information.
Published in:
Cancer Communications, 2023, v. 43, n. 1, p. 1, doi. 10.1002/cac2.12298
Publication type:
Article